Clinical trial
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
NCT00167362 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00167362 |
|---|---|
| Title | Cognitive Enhancement Therapy for Early-Stage Schizophrenia |
| Official title | Rehabilitation, Brain Function and Early Schizophrenia |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Behavioral |
| Interventions | Cognitive enhancement therapy (CET), Enriched supportive therapy (EST) |
| Enrollment | 67 |
| Start date | Aug 1, 2001 |
| Primary completion | Aug 1, 2009 |
| Completion | Dec 1, 2016 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: